Accessibility Menu
 
Auxly Cannabis Group logo

Auxly Cannabis Group

(TSX) XLY

Current Price$0.14
Market Cap$177.72M
Since IPO (1989)-91%
5 Year-63%
1 Year+63%
1 Month+13%

Auxly Cannabis Group Financials at a Glance

Market Cap

$177.72M

Revenue (TTM)

$146.00M

Net Income (TTM)

$45.34M

EPS (TTM)

$0.03

P/E Ratio

3.79

Dividend

$0.00

Beta (Volatility)

1.38 (Average)

Price

$0.14

Volume

212,962

Open

$0.14

Previous Close

$0.13

Daily Range

$0.13 - $0.14

52-Week Range

$0.07 - $0.19

XLY News

XLY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Auxly Cannabis Group

Industry

Pharmaceuticals

Employees

388

CEO

Hugo M. Alves

Headquarters

Toronto, ON M6J 0C2, CA

XLY Financials

Key Financial Metrics (TTM)

Gross Margin

60%

Operating Margin

25%

Net Income Margin

31%

Return on Equity

32%

Return on Capital

16%

Return on Assets

16%

Earnings Yield

26.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$177.72M

Shares Outstanding

1.37B

Volume

212.96K

Short Interest

0.00%

Avg. Volume

688.15K

Financials (TTM)

Gross Profit

$59.93M

Operating Income

$14.71M

EBITDA

$24.38M

Operating Cash Flow

$16.78M

Capital Expenditure

$2.76M

Free Cash Flow

$14.02M

Cash & ST Invst.

$18.50M

Total Debt

$68.47M

Auxly Cannabis Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$39.90M

+19.9%

Gross Profit

$28.15M

+64.2%

Gross Margin

70.56%

N/A

Market Cap

$177.72M

N/A

Market Cap/Employee

$458.03K

N/A

Employees

388

N/A

Net Income

$20.49M

+532.6%

EBITDA

$23.47M

+162.2%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$35.37M

+32.7%

Accounts Receivable

$23.93M

+10.2%

Inventory

$46.24M

+37.5%

Long Term Debt

$51.05M

-4.1%

Short Term Debt

$14.94M

-18.9%

Return on Assets

16.40%

N/A

Return on Invested Capital

16.21%

N/A

Free Cash Flow

$8.09M

-33.7%

Operating Cash Flow

$9.74M

-24.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LOVE.VCannara Biotech Inc.
$1.89+6.18%
RX.VBioSyent Inc.
$14.60-3.63%
CRDL.TOCardiol Therapeutics Inc.
$1.43+6.72%
CYBN.NECybin Inc.
$6.30-0.63%

Trending Stocks

Symbol / CompanyPricePrice Chg
IBRXImmunityBio
$7.09-0.25%
ONDSOndas
$10.82-0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.77-0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.63+0.01%

Questions About XLY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.